Mitochondrial DNA and Chronic Pain: Unveiling the cGAS-STING Pathway’s Role in Post-Surgical Discomfort

Explore the groundbreaking discovery of how mitochondrial DNA ignites a cellular pathway that could be the key to understanding and potentially alleviating chronic postsurgical pain in the elderly.
– by James

Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.

Activation of mitochondrial DNA-mediated cGAS-STING pathway contributes to chronic postsurgical pain by inducing type I interferons and A1 reactive astrocytes in the spinal cord.

Chen et al., Int Immunopharmacol 2023
DOI: 10.1016/j.intimp.2023.111348

Study Highlights:

  • New Insight: The study provides new evidence on how the cGAS-STING pathway, activated by mitochondrial DNA leakage, contributes to chronic postsurgical pain (CPSP) by promoting the generation of A1 reactive astrocytes in the spinal cord.
  • Importance: Understanding this mechanism is crucial as CPSP is a significant public health concern, and the cGAS-STING pathway represents a potential therapeutic target.
  • Contribution to Literature: This research builds on previous findings that A1 reactive astrocytes are involved in CPSP, by elucidating the role of the cGAS-STING pathway in this process.

Key Results:

  • The cGAS-STING pathway was activated in the spinal cord after skin/muscle incision and retraction (SMIR) in rats, a model for CPSP.
  • Administration of the STING inhibitor C-176 reduced type I interferons and A1 reactive astrocytes, and alleviated mechanical allodynia in SMIR rats.
  • Cyclosporin A, a mitochondrial permeability transition pore blocker, also decreased mitochondrial DNA leakage and cGAS-STING pathway activation, showing analgesic effects similar to C-176.
  • No synergistic effect was observed with the combined use of cyclosporin A and C-176, suggesting a common pathway.

Conclusion:

The study concludes that targeting the cGAS-STING pathway could be a promising strategy for treating CPSP, as it is implicated in the induction of A1 reactive astrocytes and type I interferons that contribute to pain.

Share this post

Posted

in

by